Truist Securities Reiterates Hold Rating on Treace Medical Concepts, Inc. (TMCI)

Market Context

Treace Medical Concepts, Inc. operates in the Healthcare sector. The stock currently trades at $4.43 with a market capitalization of $183.6M.

Analyst coverage from Truist Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Treace Medical Concepts, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Treace Medical Concepts, Inc.

Among the 10 most recent ratings: 1 Buy, 8 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 16, 2026	Truist Securities	Hold	N/A
Mar 02, 2026	Lake Street	Buy	N/A
Jan 07, 2026	Stifel	Hold	N/A
Dec 18, 2025	Truist Securities	Hold	N/A
Nov 10, 2025	Truist Securities	Hold	N/A

Related Tools: Analyst Ratings Dashboard | View TMCI Stock Page